%D8%A8%D8%A7%D9%83%D9%84%D9%8A%D8%AA%D8%A7%D9%83%D8%B3%D9%8A%D9%84PaclitaxelPaclitaxelCategory:PaclitaxelPaklitaxelPaclitacselPaclitaxelPaclitaxelPaclitaxelPaklitakseel%D9%BE%D8%A7%DA%A9%D9%84%DB%8C%D8%AA%D8%A7%DA%A9%D8%B3%D9%84PaklitakseliPaclitaxelTacs%C3%B3l%E0%A4%AA%E0%A5%87%E0%A4%B8%E0%A5%8D%E0%A4%B2%E0%A4%BF%E0%A4%9F%E0%A5%87%E0%A4%95%E0%A5%8D%E0%A4%B8%E0%A5%87%E0%A4%B2PaklitaxelPaklitakselTaxolo%E3%83%91%E3%82%AF%E3%83%AA%E3%82%BF%E3%82%AD%E3%82%BB%E3%83%AB%D0%9F%D0%B0%D0%BA%D0%BB%D0%B8%D1%82%D0%B0%D0%BA%D1%81%D0%B5%D0%BBPaclitaxelPaclitaxel%E0%AC%AA%E0%AC%BE%E0%AC%95%E0%AD%8D%E0%AC%B2%E0%AC%BF%E0%AC%9F%E0%AC%BE%E0%AC%95%E0%AD%8D%E0%AC%B8%E0%AD%87%E0%AC%B2PaklitakselPaclitaxelPaclitaxel%D0%9F%D0%B0%D0%BA%D0%BB%D0%B8%D1%82%D0%B0%D0%BA%D1%81%D0%B5%D0%BBPaklitakselPaklitakselPaklitakselPaklitaxelPaclitaxel%D0%9F%D0%B0%D0%BA%D0%BB%D1%96%D1%82%D0%B0%D0%BA%D1%81%D0%B5%D0%BBTaxoloPaclitaxelQ423762%E7%B4%AB%E6%9D%89%E9%86%87
about
P1672
Phase II Evaluation Of Paclitaxel And Cisplatin In Combination With Split Course Hyperfractionated RadiationA Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PatientsStandard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell TumorsA Study of ABT-165 in Subjects With Solid TumorsEvaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)GRN1005 for Brain Metastases From Breast or Lung CancerA Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal CancersPaclitaxel Plus Radiation Therapy in Treating Women With Stage II or Stage III Breast CancerSingapore INfra-Genicular Angioplasty With PAclitaxel-eluting Balloon for Critical Limb Ischaemia (SINGA-PACLI) TrialDrug-Coated Chocolate PTA Balloon in Patients With Peripheral Arterial Disease - The ENDURE TrialComparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCCGemcitabine and Nabpaclitaxel in Metastatic Pancreatic Carcinoma.Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6The Efficacy and Safety of SeQuent® Please in the Treatment of Small Vessel Disease (SVD) PatientANG1005 in Leptomeningeal Disease From Breast CancerAdjuvant Palbociclib in Elderly Patients With Breast CancerNab-Paclitaxel and Durvalumab With or Without Neoantigen Vaccine in Treating Patients With Metastatic Triple Negative Breast CancerSHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell CancerAtezolizumab Trial in Endometrial Cancer - AtTEndA Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid TumorsFolfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic CancerEOC202 Plus First-line Paclitaxel Phase Ⅰ Trail in Chinese Patients With Metastatic Breast CancerConventional Prophylactic Oral Dexamethasone vs Short-course IV Dexamethasone in Paclitaxel HypersensitivityPU-H71 With Nab-paclitaxel (Abraxane) in Metastatic Breast CancerAPX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction CancersA Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer PatientsBiweekly SOLAR, as First-line C/T in Pts With Gastric, Pancreatic and Biliary CancersPCB for Long De Novo Lesions of Main Coronary Arteries (D-Lesion Long Trial)Evaluation of the Safety and Tolerability of TAK-228 With TAK-117 and Paclitaxel in Advanced Solid TumorsPhase 2 Study of ABT-869 in Combination With Paclitaxel Versus Paclitaxel Alone to Treat Metastatic Breast CancerCarboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung CancerDose Escalation Study of Liposomal Paclitaxel With/Without Capecitabine in Patients With Advanced Gastric CarcinomaParicalcitol and Chemotherapy in Treating Women With Metastatic Breast CancerTherapy for Locally Advanced Breast Cancer Using Doxil, Paclitaxel, and Cyclophosphamide With AvastinTrial of E10A in Head and Neck CancerSafety Study to Assess the Feasibility of Use in Humans of the TAXUS Petal Bifurcation Coronary Stent SystemPhase I Study in Patients With Solid TumoursTitanium Nitride Oxide Coated Stents and Paclitaxel Eluting Stents for Acute Myocardial InfarctionSorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell Cancer
P4844
response to paclitaxelpaclitaxel metabolic processpaclitaxel biosynthetic processcellular response to paclitaxelIntegrated Breast Cancer Pathwaycarboplatin / paclitaxel / sorafenib combination therapycarboplatin / paclitaxel combination therapycisplatin / paclitaxel combination therapyCYP2C8 inactivates paclitaxel by 6alpha-hydroxylationbuparlisib / paclitaxel / carboplatin combination therapycyclophosphamide hydrate / doxorubicin / fluorouracil / epirubicin / paclitaxel combination therapyTrastuzumab / paclitaxel combination therapyProtein-bound paclitaxelcarboplatin / buparlisib / paclitaxel combination therapy
P527
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Paclitaxel
@ast
Paclitaxel
@de
Paclitaxel
@nb
Paclitaxel
@nl
Paclitaxel
@ro
Paclitaxel
@tl
Paclitaxel
@vi
Paklitakseel
@et
Paklitaksel
@id
Paklitaksel
@sh
type
label
Paclitaxel
@ast
Paclitaxel
@de
Paclitaxel
@nb
Paclitaxel
@nl
Paclitaxel
@ro
Paclitaxel
@tl
Paclitaxel
@vi
Paklitakseel
@et
Paklitaksel
@id
Paklitaksel
@sh
altLabel
33069-62-4
@fr
5beta,20-Epoxy-1,2-alpha,4,7be ...... S)-N-benzoyl-3-phenylisoserine
@en
Abraxane
@de
Abraxen
@cs
Anzatax
@en
BMS-181339-01
@en
Baccatine
@nl
C47H51NO14
@fr
C47H51NO14
@it
Capxol
@en
prefLabel
Paclitaxel
@ast
Paclitaxel
@de
Paclitaxel
@nb
Paclitaxel
@nl
Paclitaxel
@ro
Paclitaxel
@tl
Paclitaxel
@vi
Paklitakseel
@et
Paklitaksel
@id
Paklitaksel
@sh